Literature DB >> 25222168

Guidelines for the care of pregnant women living with HIV and interventions to reduce perinatal transmission: executive summary.

Deborah Money1, Karen Tulloch1, Isabelle Boucoiran2, Sheila Caddy3.   

Abstract

OBJECTIVE: This guideline reviews the evidence relating to the care of pregnant women living with HIV and the prevention of perinatal HIV transmission. Prenatal care of pregnancies complicated by HIV infection should include monitoring by a multidisciplinary team with experts in this area. OUTCOMES: OUTCOMES evaluated include the impact of HIV on pregnancy outcome and the efficacy and safety of antiretroviral therapy and other measures to decrease the risk of vertical transmission. EVIDENCE: Published literature was retrieved through searches of PubMed and The Cochrane Library in 2012 and 2013 using appropriate controlled vocabulary (HIV, anti-retroviral agents, pregnancy, delivery) and key words (HIV, pregnancy, antiretroviral agents, vertical transmission, perinatal transmission). Results were restricted to systematic reviews, randomized control trials/controlled clinical trials, and observational studies published in English or French. There were no date restrictions. Searches were updated on a regular basis and incorporated in the guideline to June 2013. Grey (unpublished) literature was identified through searching the websites of health technology assessment and health technology-related agencies, clinical practice guideline collections, clinical trial registries, and national and international medical specialty societies. VALUES: The quality of evidence in this document was rated using the criteria described in the Report of the Canadian Task Force on Preventive Health Care (Table 1).

Entities:  

Keywords:  HIV; antiretroviral agents; perinatal transmission; pregnancy; vertical transmission

Mesh:

Year:  2014        PMID: 25222168     DOI: 10.1016/S1701-2163(15)30515-6

Source DB:  PubMed          Journal:  J Obstet Gynaecol Can        ISSN: 1701-2163


  10 in total

1.  Missed opportunities for prevention of vertical HIV transmission in Canada, 1997-2016: a surveillance study.

Authors:  Ari Bitnun; Terry Lee; Jason Brophy; Lindy M Samson; Fatima Kakkar; Wendy Vaudry; Ben Tan; Deborah M Money; Joel Singer; Laura J Sauvé; Ariane Alimenti
Journal:  CMAJ Open       Date:  2018-05-10

2.  The Prevalence of HIV-Positive Infants Born to HIV-Positive Mothers Attended at the University of Gondar Specialized Hospital Anti-Retroviral Therapy Services, Northwest Ethiopia, 2018.

Authors:  Destaye Guadie Kassie; Worknesh Akanaw Bogale; Ayenew Addisu
Journal:  HIV AIDS (Auckl)       Date:  2020-03-26

3.  An observational study of initial HIV RNA decay following initiation of combination antiretroviral treatment during pregnancy.

Authors:  Jasmini Alagaratnam; Helen Peters; Kate Francis; Natasha Kay; Yvonne Gilleece; Fionnuala P Finnerty; Rosanna E Grimes; Sarah Parry; Mags Portman; Brenton C Wait; Rimi Shah; Sherie Roedling; David A Hawkins; Sarah Chitty; Liat Sarner; Rebecca Marcus; Anna Hartley; Achyuta V Nori; Melanie Rosenvinge; Graham P Taylor
Journal:  AIDS Res Ther       Date:  2020-07-13       Impact factor: 2.250

4.  Periconceptional exposure to lopinavir, but not darunavir, impairs decidualization: a potential mechanism leading to poor birth outcomes in HIV-positive pregnancies.

Authors:  Smriti Kala; Caroline Dunk; Sebastian Acosta; Lena Serghides
Journal:  Hum Reprod       Date:  2020-08-01       Impact factor: 6.918

5.  Dynamics of leukocyte telomere length in pregnant women living with HIV, and HIV-negative pregnant women: A longitudinal observational study.

Authors:  Sara Saberi; Steve E Kalloger; Mayanne M T Zhu; Beheroze Sattha; Evelyn J Maan; Julianne van Schalkwyk; Deborah M Money; Hélène C F Côté
Journal:  PLoS One       Date:  2019-03-06       Impact factor: 3.240

6.  Cost-effectiveness analysis of infant feeding modalities for virally suppressed mothers in Canada living with HIV.

Authors:  Reyhaneh Keshmiri; Peter C Coyte; Audrey Laporte; Prameet M Sheth; Mona Loutfy
Journal:  Medicine (Baltimore)       Date:  2019-06       Impact factor: 1.817

Review 7.  Cabergoline: a review of its use in the inhibition of lactation for women living with HIV.

Authors:  Karen J Tulloch; Philippe Dodin; Fannie Tremblay-Racine; Chelsea Elwood; Deborah Money; Isabelle Boucoiran
Journal:  J Int AIDS Soc       Date:  2019-06       Impact factor: 5.396

8.  A case series of third-trimester raltegravir initiation: Impact on maternal HIV-1 viral load and obstetrical outcomes.

Authors:  I Boucoiran; K Tulloch; N Pick; F Kakkar; J van Schalkwyk; D Money; M Boucher
Journal:  Can J Infect Dis Med Microbiol       Date:  2015 May-Jun       Impact factor: 2.471

Review 9.  Is Cabergoline Safe and Effective for Postpartum Lactation Inhibition? A Systematic Review.

Authors:  Yang Yang; Isabelle Boucoiran; Karen J Tulloch; Vanessa Poliquin
Journal:  Int J Womens Health       Date:  2020-03-09

10.  Preventive measures to avoid vertical transmission in untreated pregnant women with HIV/AIDS.

Authors:  Sara Rincón Franco; Montserrat Uriel; Luis Martín Rodríguez; Ximena Carolina Romero Infante
Journal:  BMJ Case Rep       Date:  2020-03-25
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.